# Efficacy and Safety of Tianzhi Granule in Mild to Moderate Vascular Dementia

> **NCT02453932** · PHASE3 · COMPLETED · sponsor: **Dongzhimen Hospital, Beijing** · enrollment: 543 (actual)

## Conditions studied

- Vascular Dementia

## Interventions

- **DRUG:** Tianzhi granule and placebo identified to donepezil
- **DRUG:** Donepezil and placebo identified to Tianzhi granule
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02453932
- **Lead sponsor:** Dongzhimen Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2017-05
- **Final completion:** 2017-05
- **Target enrollment:** 543 (ACTUAL)
- **Last updated:** 2020-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02453932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02453932, "Efficacy and Safety of Tianzhi Granule in Mild to Moderate Vascular Dementia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02453932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*